Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 12.3% in the afternoon session after the company reported better-than-expected first-quarter 2026 results.

Novavax on Wednesday beat Wall Street estimates for first-quarter revenue, as upfront and milestone payments from vaccine ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including Novavax (NASDAQ:NVAX) and its peers.

Novavax recently made a move that improved its financial position and prospects. The biotech has two pivotal clinical trials in the works. Those headwinds included the difficulties it faced in ...

Novavax received emergency use authorization for an updated vaccine. The biotech is benefiting from a partnership with Sanofi. However, its prospects remain unpredictable. Though we are no longer in a ...

GAITHERSBURG, Md., Oct. 11, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will present study findings during two ...

Its licensing, royalties, and other revenue rose to $97 million in Q1, up from $45 million a year earlier. ・Novavax is ...

Vaccine biotechnology company Novavax (NASDAQ:NVAX) will be reporting results this Wednesday before market open. Here’s what ...

Five years ago, Novavax (NASDAQ: NVAX) was a little-known clinical-stage biotech whose leading pipeline candidate was an influenza vaccine. Then came the pandemic. The company quickly grew in ...

Add Yahoo as a preferred source to see more of our stories on Google. Novavax, sold under the brand name Nuvaxovid, is a protein-based COVID-19 vaccine — the same technology used to develop many other ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...

A third COVID-19 vaccine, made by Novavax, will soon be available in pharmacies and doctor's offices. The Food and Drug Administration Tuesday authorized use of the Novavax vaccine, which is based on ...